QuidelOrtho Shares Drop on Carlyle's Secondary Offering

Dow Jones

2024-11-20

By Dean Seal

Shares of QuidelOrtho fell after the company said Carlyle Group was selling 8.26 million of its shares in an underwritten secondary offering.

The stock was down 7.3% at $35.75 in premarket trading on Wednesday. Shares had already fallen 48% year-to-date when the market closed Tuesday.

The maker of an at-home Covid-19 test and other products said after yesterday's closing bell that Carlyle Group would sell the shares in an offering set to close on Nov. 21. QuidelOrtho will not receive any proceeds from the offering.

Goldman Sachs is acting as the sole underwriter and will offer the shares to the public at a fixed price, the company said.

QuidelOrtho issued a press release on Tuesday night saying the offering had been priced, though it didn't provide the per-share price.

Write to Dean Seal at dean.seal@wsj.com

(END) Dow Jones Newswires

November 20, 2024 07:26 ET (12:26 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2484190510"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2484190510\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2484190510?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-20 20:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2484190510","market":"hk","top_or_hot":-1,"title":"QuidelOrtho Shares Drop on Carlyle's Secondary Offering","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n     By Dean Seal \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of QuidelOrtho fell after the company said Carlyle Group was selling 8.26 million of its shares in an underwritten secondary offering. \n</p>\n<p>\n  The stock was down 7.3% at $35.75 in premarket trading on Wednesday. Shares had already fallen 48% year-to-date when the market closed Tuesday. \n</p>\n<p>\n  The maker of an at-home Covid-19 test and other products said after yesterday's closing bell that Carlyle Group would sell the shares in an offering set to close on Nov. 21. QuidelOrtho will not receive any proceeds from the offering. \n</p>\n<p>\n  Goldman Sachs is acting as the sole underwriter and will offer the shares to the public at a fixed price, the company said. \n</p>\n<p>\n  QuidelOrtho issued a press release on Tuesday night saying the offering had been priced, though it didn't provide the per-share price. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Dean Seal at dean.seal@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 20, 2024 07:26 ET (12:26 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>QuidelOrtho Shares Drop on Carlyle's Secondary Offering</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQuidelOrtho Shares Drop on Carlyle's Secondary Offering\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2024-11-20 20:26</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n     By Dean Seal \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of QuidelOrtho fell after the company said Carlyle Group was selling 8.26 million of its shares in an underwritten secondary offering. \n</p>\n<p>\n  The stock was down 7.3% at $35.75 in premarket trading on Wednesday. Shares had already fallen 48% year-to-date when the market closed Tuesday. \n</p>\n<p>\n  The maker of an at-home Covid-19 test and other products said after yesterday's closing bell that Carlyle Group would sell the shares in an offering set to close on Nov. 21. QuidelOrtho will not receive any proceeds from the offering. \n</p>\n<p>\n  Goldman Sachs is acting as the sole underwriter and will offer the shares to the public at a fixed price, the company said. \n</p>\n<p>\n  QuidelOrtho issued a press release on Tuesday night saying the offering had been priced, though it didn't provide the per-share price. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Dean Seal at dean.seal@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 20, 2024 07:26 ET (12:26 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE00B64PRP62.GBP","symbol_name":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (GBP) ACC","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2484190510","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2484190510","pubTimestamp":1732105560,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of QuidelOrtho fell after the company said Carlyle Group was selling 8.26 million of its shares in an underwritten secondary offering.The stock was down 7.3% at $35.75 in premarket trading on Wednesday. Shares had already fallen 48% year-to-date when the market closed Tuesday.The maker of an at-home Covid-19 test and other products said after yesterday's closing bell that Carlyle Group would sell the shares in an offering set to close on Nov. 21. QuidelOrtho will not receive any proceeds from the offering.Goldman Sachs is acting as the sole underwriter and will offer the shares to the public at a fixed price, the company said.QuidelOrtho issued a press release on Tuesday night saying the offering had been priced, though it didn't provide the per-share price.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IE00B64PRP62.GBP":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (GBP) ACC","QDEL":"窥得儿医药","BK4198":"医疗保健用品","IE00B3QW5Z07.USD":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (USD) ACC","BK4135":"资产管理与托管银行","IE00BGHQF748.EUR":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (EUR) ACC","BK4082":"医疗保健设备","CG":"凯雷"},"translate_title":"凯雷二次发行导致QuidelOrtho股价下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CG":0.9,"QDEL":0.9},"content_text":"By Dean Seal \n\n\n \n\n\n  Shares of QuidelOrtho fell after the company said Carlyle Group was selling 8.26 million of its shares in an underwritten secondary offering. \n\n\n  The stock was down 7.3% at $35.75 in premarket trading on Wednesday. Shares had already fallen 48% year-to-date when the market closed Tuesday. \n\n\n  The maker of an at-home Covid-19 test and other products said after yesterday's closing bell that Carlyle Group would sell the shares in an offering set to close on Nov. 21. QuidelOrtho will not receive any proceeds from the offering. \n\n\n  Goldman Sachs is acting as the sole underwriter and will offer the shares to the public at a fixed price, the company said. \n\n\n  QuidelOrtho issued a press release on Tuesday night saying the offering had been priced, though it didn't provide the per-share price. \n\n\n \n\n\n  Write to Dean Seal at dean.seal@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 20, 2024 07:26 ET (12:26 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}